Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Accumulated Depreciation (2016 - 2024)

Historic Accumulated Depreciation for Ernexa Therapeutics (ERNA) over the last 10 years, with Q4 2024 value amounting to $172000.0.

  • Ernexa Therapeutics' Accumulated Depreciation rose 5087.72% to $172000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $172000.0, marking a year-over-year increase of 5087.72%. This contributed to the annual value of $172000.0 for FY2024, which is 5087.72% up from last year.
  • Latest data reveals that Ernexa Therapeutics reported Accumulated Depreciation of $172000.0 as of Q4 2024, which was up 5087.72% from $114000.0 recorded in Q4 2023.
  • Ernexa Therapeutics' 5-year Accumulated Depreciation high stood at $172000.0 for Q4 2024, and its period low was $32000.0 during Q4 2022.
  • Over the past 5 years, Ernexa Therapeutics' median Accumulated Depreciation value was $120000.0 (recorded in 2020), while the average stood at $116680.0.
  • Its Accumulated Depreciation has fluctuated over the past 5 years, first crashed by 9869.18% in 2020, then surged by 25625.0% in 2023.
  • Ernexa Therapeutics' Accumulated Depreciation (Quarter) stood at $120000.0 in 2020, then rose by 21.17% to $145400.0 in 2021, then tumbled by 77.99% to $32000.0 in 2022, then soared by 256.25% to $114000.0 in 2023, then skyrocketed by 50.88% to $172000.0 in 2024.
  • Its Accumulated Depreciation was $172000.0 in Q4 2024, compared to $114000.0 in Q4 2023 and $32000.0 in Q4 2022.